How GLP-1 Medications Work for Weight Loss
What GLP-1 and GIP receptors actually do, and why these medications change appetite and fullness.
GLP-1 medications have become the most talked-about tool in weight management, but most explanations jump straight to brand names without explaining what the medication actually does in your body. Understanding the mechanism helps you set realistic expectations and have a more useful conversation with a provider.
Here is a clear walk-through of how GLP-1 (and GLP-1/GIP) medications work, in everyday language.
What GLP-1 is
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally releases after you eat. It helps signal fullness to the brain, slows how quickly the stomach empties, and supports healthy blood-sugar regulation. GLP-1 medications are receptor agonists — they act on the same receptors this natural hormone uses, but with a much longer-lasting effect.
What the medication does
- Appetite: by acting on receptors in the brain, these medications can reduce hunger and the frequency of food cravings for many people.
- Fullness: food stays in the stomach a little longer, so you may feel satisfied sooner and for longer after a meal.
- Blood sugar: GLP-1 supports insulin release when blood sugar is high, which is why the same molecules are also used in diabetes care.
The combined effect is that many people find it easier to eat less without the constant hunger that usually derails calorie reduction. The medication is a tool that works alongside — not instead of — nutrition and activity changes.
Semaglutide vs. tirzepatide: one receptor or two
Semaglutide (the molecule in Wegovy and Ozempic) acts on the GLP-1 receptor. Tirzepatide (the molecule in Zepbound and Mounjaro) acts on two receptors — GLP-1 and GIP — which is why it is described as a "dual agonist." Both are once-weekly injectables used under provider supervision. Which one suits you depends on your history, goals, and tolerance, and is a decision for a licensed provider.
About compounded medications
Compounded semaglutide and tirzepatide are prepared by state-licensed 503A compounding pharmacies for an individual patient after a provider consultation. They are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are only appropriate when a licensed provider determines they are clinically suitable for you.
Why dose titration matters
GLP-1 medications are started at a low dose and increased gradually over weeks. This "titration" gives your body time to adjust and helps limit side effects like nausea. Skipping ahead on dose is not safer or faster — it tends to make side effects worse. Your provider sets the schedule.
Talk to a licensed provider
This article is general education, not medical advice. Dosing, side effects, and whether a GLP-1 is right for you are decisions to make with a US-licensed provider who has reviewed your full medical history.
See if a GLP-1 is right for you
Complete a short online intake. A US-licensed provider reviews your history and goals — no insurance required.
Start your free assessmentFrequently asked questions
Do GLP-1 medications work without diet and exercise?
GLP-1 medications are designed to be used alongside nutrition and activity changes, not as a replacement for them. They make appetite easier to manage, but sustainable results come from combining the medication with supportive habits.
How quickly do GLP-1 medications start working?
Many people notice reduced appetite within the first few weeks, but dose is increased gradually and weight changes are typically steady rather than sudden. Individual response varies.
Is the compounded version the same as the brand?
Compounded semaglutide and tirzepatide use the same molecule as their branded counterparts, but they are prepared by a licensed 503A pharmacy for an individual patient and are not FDA-approved. Only a licensed provider can decide whether a compounded option is appropriate for you.
This article is for general education and is not medical advice. It does not establish a provider-patient relationship. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies, are not FDA-approved, and are only appropriate when a licensed provider determines they are suitable for you. Prescribing and treatment decisions are made independently by licensed providers. You must be 21 or older to use ZENKAI. Results vary.